Target intelligence / Profile preview

Hepatic artery sympathetic nerve fiber

Molecular classification
Other
01

Overview

Hepatic artery sympathetic nerve fibers are postganglionic components of the autonomic (sympathetic) nervous system originating from the celiac and superior mesenteric ganglia, running alongside the hepatic artery into the liver. They release neurotransmitters (like noradrenaline) that regulate vascular tone, blood flow, and hepatic stellate cell activation, influencing liver metabolism, regeneration, and fibrosis. In chronic liver diseases such as hepatitis and cirrhosis, the density of these fibers is reduced, contributing to altered homeostasis and potentially poor recovery after liver injury or transplantation. These fibers are not classified as a canonical “therapeutic target” (such as a receptor, enzyme, or transporter), but modulation of their signaling or function affects liver disease outcomes and is an area of experimental investigation. Key clarifications: - This is not a single molecule, gene, or receptor, but rather a population of nerve fibers important for liver physiology. - It should not be listed as a conventional molecular target for drug discovery. - Drugs targeting these fibers would act indirectly (e.g., via adrenergic receptor antagonists/agonists) but there are no drugs that specifically and selectively target these fibers as a therapeutic class.

Other names
Hepatic sympathetic nerve fiberLiver sympathetic nerve fiberSympathetic fibers of hepatic artery
02

Biological functions

Regulation of hepatic blood flowModulation of hepatic metabolism (including glucose and lipid metabolism)Influence on bile secretionParticipation in liver regeneration and fibrosis
03

Disease associations

Cardiovascular disease (via blood flow regulation)Liver fibrosis and cirrhosisMetabolic diseases such as obesity, dyslipidemia, and diabetes mellitusOther hepatic pathologies related to denervation or autonomic dysfunction
04

Safety considerations

Hepatic denervation due to surgery (e.g., transplantation) may contribute to metabolic dysregulation (obesity, diabetes, hyperlipidemia, hypertension)Loss of these fibers is associated with liver fibrosis progression

Beyond the preview

Go deeper on Hepatic artery sympathetic nerve fiber.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatic artery sympathetic nerve fiber.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call